Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000038

Chief Scientific Officer sold 2,550 shares at an average $16.78 ($42,783)

From the SEC's structured data for this filing

Trades in this filing

Jewell Christopher M · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-03 Sale : show line 1 in the form −1,264 $16.72 $21,136 54,776 D
2025-01-06 Sale : show line 2 in the form −1,286 $16.83 $21,646 53,490 D
Open-market sales · 2,550 sh · avg $16.78 · $42,783
Loading xslF345X05/wk-form4_1736298315.xml…